Amazon Going Nuclear? Hiring Plans Indicate Company May Be Eyeing Nuclear To Meet Energy Needs Recent developments suggest that Amazon may be ramping up its interest in nuclear energy to fuel its ...

The Mega Millions jackpot has grown to an estimated $250 million for Tuesday's drawing after no one claimed the top prize on Friday. The winning numbers were drawn just after 11 p.m. on Friday and ...

There will be at least two versions of 2025 KTM 390 Adventure, one focused on off-road and the other for road-oriented touring At EICMA 2024, KTM will be unveiling multiple new models and ...

The new-gen KTM 390 Adventure R will be the more feature-laden version of the adventure offering. The leaked details reveal the 21-inch front and 18-inch rear wire-spoked wheels, a new H50 TFT ...

The 2025 KTM 390 Adventure is on the horizon and shortly before the launch, we’ve got access to the specifications and features of one of the variants. The KTM 390 Adventure X is likely to be the more ...

The R is an off-road-focused version, while the X is more road-biased. Details of the 2025 KTM 390 Adventure have leaked online ahead of its official debut at EICMA 2024 in Milan, Italy. The recent ...

Roche has inked a new deal with Dyno Ther­a­peu­tics to de­vel­op next-gen­er­a­tion AAV cap­sids for gene ther­a­pies tar­get­ing neu­ro­log­i­cal dis­eases, ex­pand­ing the ...

After forming a gene therapy partnership with Dyno Therapeutics in 2020, Roche is back for more. In a new deal potentially worth more than $1 billion, Roche is paying Dyno $50 million upfront to ...

KTM have launched yet another version of their 2025 1390 Super Adventure S, this time with a traditional manual gearbox. Related: Bosch launch six new radar cruise features with KTM The Super ...

KTM hasn't revealed pricing for the 2025 model, which will be produced in Austria. But given that the 2024 1290 Super Adventure S started at just under US$24,000, it'll likely be in that ballpark.

New strategic partnership leverages the power of the Dyno platform, enabling Roche to advance next-generation AAV gene therapies across multiple targets Dyno to receive US$50 million upfront cash ...

Roche will apply Dyno Therapeutics’ engineered adeno-associated virus (AAV) capsid platform to develop next-generation AAV vectors for gene therapies targeting unspecified neurological diseases ...